Having trouble viewing this email? View in your browser.
Weekly News
22 June 2021

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

New ESCMID newsletter layout

We are very pleased to introduce a new layout of the ESCMID weekly newsletter, allowing a quicker overview of the society’s activities at a glance.
We look forward to continuing to share the latest ESCMID news with you each Tuesday.

ECCMID 2021 granted European CME accreditation

The 31st European Congress of Clinical Microbiology & Infectious Diseases, to be held online from 09/07/2021-12/07/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 32 European CME credits (ECMEC®s).
Find out more on the ECCMID website.

Last chance to register – Rare Yeasts: A Growing Threat

Don’t miss your chance to register for the next ESCMID Online Education Course, hosted in collaboration with ECMM - ‘Rare Yeasts: A Growing Threat’
Registrations will close on 25 June, 2021.
Click here to view the course flyer.

Register for this as well as other courses, on the online courses website.

GARDP AMR Discussions: Balancing access to and stewardship of antimicrobials in LMICs

On 1st July 2021, GARDP will be launching a new series of webinars: AMR Discussions. In the first of these, we will be addressing the question of how to balance equitable access to antibiotics with the lack of stewardship of these life-saving drugs in LMICs. Philip Howard will moderate this webinar in which Direk Limmathurotsakul, Souha S. Kanj and Sujith J. Chandy will discuss this topic.

The webinar will run from 10:00-11:00 CEST on 1 July 2021.

Two weeks left: ‘Treatment guidance document for Clostridioides difficile infection in adults” draft manuscript

If you wish participate to the Public Consultation Phase, please write to guidancedocuments@escmid.org indicating your ESCMID membership number.

You will receive the confidential manuscript, along with the comments form for listing feedback and the together with the template to register their comments and the AGREE GLOBAL RATING SCALE form to be completed (More information about the AGREE II tool can be found here).
The deadline to provide feedback and comments is 5 July 2021.

CMI highlight: Microbiology of hip and knee periprosthetic joint infections: A database study

Knowledge of the microbiologic etiology of periprosthetic joint infection (PJI) is essential to its management. Contemporary literature from the United States on this topic is lacking. This study aimed to identify the most common microorganisms associated with types of arthroplasty, the timing of infection, and clues to polymicrobial infection.
A total of 2,067 episodes of PJI in 1,651 patients were included in this cross-sectional study.